1996PubMedRequires access

[Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].

Andrey Korshunov, Regina Sycheva

Open publisher page 1 citations

Abstract

Expression of the glial fibrillary acidic protein (GFAP) and S-100 protein was examined in 76 astrocytic gliomas (AG) with different degree of malignancy, which were subdivided into 4 groups: pilocytic astrocytoma, mixed astrocytoma, anaplastic astrocytoma and glioblastoma. Combined light-microscopical and immunohistochemical investigation detected several variants among different kinds of malignant AG that were distinguished by cytological composition and immunomorphology. Gemistocytic and polymorphic nuclear types were distinguished among anaplastic astrocytoma. Glioblastomas were subdivided into multiforme, isomorphic and gemistocytic variants. It was established that fractions of GFAP-negative cells occur in benign and malignant AG. Thus, the presence of population of immunonegative cells in AG is not a sign of high-grade tumor anaplasia. Groups of GFAP-positive cells around tumor vessels were found in malignant AG only.

About this research paper

What this paper is about

Expression of the glial fibrillary acidic protein (GFAP) and S-100 protein was examined in 76 astrocytic gliomas (AG) with different degree of malignancy, which were subdivided into 4 groups: pilocytic astrocytoma, mixed astrocytoma, anaplastic astrocytoma and glioblastoma. Combined light-microscopical and immunohistochemical investigation detected several variants among different kinds of malignant AG that were distinguished by cytological composition and immunomorphology. Gemistocytic and polymorphic nuclear types were distinguished among anaplastic astrocytoma. Glioblastomas were subdivided into multiforme, isomorphic and gemistocytic variants. It was established that fractions of GFAP-negative cells occur in benign and malignant AG. Thus, the presence of population of immunonegative cells in AG is not a sign of high-grade tumor anaplasia. Groups of GFAP-positive cells around tumor vessels were found in malignant AG only.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Expression of the glial fibrillary acidic protein (GFAP) and S-100 protein was examined in 76 astrocytic gliomas (AG) with different degree of malignancy, which were subdivided into 4 groups: pilocytic astrocytoma, mixed astrocytoma, anaplastic astrocytoma and glioblastoma. Combined light-microscopical and immunohistochemical investigation detected several variants among different kinds of malignant AG that were distinguished by cytological composition and immunomorphology. Gemistocytic and polymorphic nuclear types were distinguished among anaplastic astrocytoma. Glioblastomas were subdivided into multiforme, isomorphic and gemistocytic variants. It was established that fractions of GFAP-negative cells occur in benign and malignant AG. Thus, the presence of population of immunonegative cells in AG is not a sign of high-grade tumor anaplasia. Groups of GFAP-positive cells around tumor vessels were found in malignant AG only.

Key concepts: Glial fibrillary acidic protein, Astrocytoma, Pathology, Anaplastic astrocytoma, Immunohistochemistry, Anaplasia, Malignancy, GFAP stain

Related papers

Back to paper searchBrowse research topicsOriginal source
[Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)]. — Research Paper | ScholarLens